Longitude Capital

Congratulations to 89bio CEO Rohan Palekar for being named to PharmaVoice’s list of industry leaders reshaping the pharma world! Learn more about 89bio’s work developing cardiometabolic solutions to treat diseases that affect millions: https://lnkd.in/gUkskmDc

Congratulations to Longitude portfolio company Ceribell │ AI-Powered Point-of-Care EEG on its IPO and Nasdaq listing! Ceribell is revolutionizing seizure management in acute care with its AI-powered point-of-care EEG diagnostic system. Exciting to see the team achieve this major milestone! 

Longitude portfolio company Cohere Health and MCG Health are partnering to improve the prior authorization process for providers, patients, and health plans. “MCG Health is the perfect partner to complement Cohere’s groundbreaking, AI-driven offering with industry-leading and nationally recognized clinical criteria,” said Cohere CEO Siva Namasivayam. “Our leading, proven technology innovations applied to MCG’s substantial clinical guidelines footprint will accelerate a new era of less prior authorization friction. Healthcare constituents are increasingly demanding innovative solutions that provide lower costs and faster access to care.” Read more about the partnership: https://lnkd.in/ePgJPbvw #HealthTech #artificialintelligence

Congratulations to Dr. Eric Adler, Chief Medical Officer and Head of Research at Lexeo Therapeutics, on being named to the 2024 PharmaVoice list of industry leaders reshaping the pharma world. Dr. Adler told PharmaVoice that he is particularly excited to influence the future of #GeneTherapy as the burgeoning scientific field moves into its next phase. “Right now technology is moving at a breakneck speed, specifically in genetic medicines, which is enabling the translation of bench discoveries to the bedside at a previously unheard of pace,” He says. “Not only is the evolution of genetic medicine technology accelerating translation, but it is also giving us the ability to truly address the root cause of genetic disease and not just treat the symptoms.” Explore the full list and meet Dr. Adler: https://lnkd.in/e9pFrenZ #pharma #biotech

Longitude portfolio company Cohere Health uses #AI to streamline and expedite prior authorization for healthcare services, aiming to enhance both patient care and administrative efficiency. The company has just been named one of LinkedIn's top 50 startups of 2024! The list contains companies that are growing fast and garnering attention from investors and jobseekers in addition to shaping the future of their respective industries. Explore the full list: https://lnkd.in/eKNN4pQm #Startups

Longitude portfolio company Vera Therapeutics, Inc.'s ORIGIN Phase 2b clinical data of atacicept in #IgANephropathy has been recognized as a finalist for the Scrip Awards' Clinical Advance of the Year. The trial showed that atacicept stabilized kidney function through 72 weeks and led to rapid improvements in hematuria. Read more about the data: https://lnkd.in/eRcDMqd5 #BioTech

Longitude portfolio company Rivus Pharmaceuticals announced new clinical data from the Phase 2a HuMAIN trial demonstrating significant weight loss with HU6 in patients with obesity-related heart failure. HU6 is the company's novel, oral, once-daily, potentially first-in-class investigational treatment. It's a Controlled Metabolic Accelerator (CMA), which promotes sustained body fat loss while preserving muscle mass.  Data from the trial showed that patients treated with HU6 experienced fat-selective weight loss, reductions in visceral fat, no changes in lean body mass, and a trend toward a reduction in inflammation. Read more: https://lnkd.in/e25rSKUn #MetabolicHealth #ObesityMedicine

Nalu Medical, Inc. Founder and CTO Lee Hartley has been named one of the Top 50 #MedTech Entrepreneurs of 2024 by Great Entrepreneurs! Nalu is a medical technology company focused on developing and commercializing innovative and minimally invasive solutions for patients with chronic neuropathic pain. Learn more about Nalu’s Neurostimulation System and Hartley’s work: https://lnkd.in/gVmBwBnH

Longitude portfolio company Cohere Health is one of IVP's list of 35 companies to watch in the Health AI space! Here's what the list shares about Cohere ⬇ "Prior authorization requires physicians to get insurance approval before they can prescribe a specific medication or deliver a certain type of care. It’s a labor-intensive and error-prone process with long lead times due to doctor and nurse shortages. Companies like Tandem Health and Cohere Health are speeding up the process, saving payers time and money." Read more at https://lnkd.in/egNcDrAm  #PriorAuthorization #FutureOfHealth

Longitude portfolio company BioAge Labs develops therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of aging—and it just closed its IPO. Congratulations to CEO Kristen Fortney and the whole team on this exciting milestone! Read more: https://lnkd.in/g9kyj6xT #BioTech